Report Detail
Global Factor IX Complex Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4742308 |
- 28 September, 2026 |
- Global |
- 77 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Factor IX Complex Drug market size was valued at US$ 1187 million in 2025 and is forecast to a readjusted size of US$ 2510 million by 2032 with a CAGR of 11.4% during review period.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The market factors is increasing prescription of anticoagulants, especially warfarin, as well as rising prevalence of bleeding disorders. Additionally, PCC offers various advantages over Fresh-frozen plasma and others, making it a more suitable option for life-threatening conditions. Apart from this, active government support for the use of 4-factor PCC products such as Kcentra and positive recommendations are anticipated to provide considerable momentum to the market.
This report is a detailed and comprehensive analysis for global Factor IX Complex Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Factor IX Complex Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Factor IX Complex Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Factor IX Complex Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Factor IX Complex Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Factor IX Complex Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Factor IX Complex Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Factor IX Complex Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Market segment by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Major players covered
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Factor IX Complex Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Factor IX Complex Drug, with price, sales quantity, revenue, and global market share of Factor IX Complex Drug from 2021 to 2026.
Chapter 3, the Factor IX Complex Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Factor IX Complex Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Factor IX Complex Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Factor IX Complex Drug.
Chapter 14 and 15, to describe Factor IX Complex Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Factor IX Complex Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Beriplex
- 1.3.3 Profilnine
- 1.3.4 Octaplex
- 1.3.5 Prothromplex
- 1.3.6 Cofact
- 1.3.7 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Factor IX Complex Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hemophilia B
- 1.4.3 Acquired Coagulation Factor Deficiency
- 1.5 Global Factor IX Complex Drug Market Size & Forecast
- 1.5.1 Global Factor IX Complex Drug Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Factor IX Complex Drug Sales Quantity (2021-2032)
- 1.5.3 Global Factor IX Complex Drug Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 CSL Behring
- 2.1.1 CSL Behring Details
- 2.1.2 CSL Behring Major Business
- 2.1.3 CSL Behring Factor IX Complex Drug Product and Services
- 2.1.4 CSL Behring Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 CSL Behring Recent Developments/Updates
- 2.2 Grifols
- 2.2.1 Grifols Details
- 2.2.2 Grifols Major Business
- 2.2.3 Grifols Factor IX Complex Drug Product and Services
- 2.2.4 Grifols Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Grifols Recent Developments/Updates
- 2.3 Octapharma
- 2.3.1 Octapharma Details
- 2.3.2 Octapharma Major Business
- 2.3.3 Octapharma Factor IX Complex Drug Product and Services
- 2.3.4 Octapharma Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Octapharma Recent Developments/Updates
- 2.4 Prothya Biosolutions
- 2.4.1 Prothya Biosolutions Details
- 2.4.2 Prothya Biosolutions Major Business
- 2.4.3 Prothya Biosolutions Factor IX Complex Drug Product and Services
- 2.4.4 Prothya Biosolutions Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Prothya Biosolutions Recent Developments/Updates
- 2.5 Takeda
- 2.5.1 Takeda Details
- 2.5.2 Takeda Major Business
- 2.5.3 Takeda Factor IX Complex Drug Product and Services
- 2.5.4 Takeda Factor IX Complex Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Takeda Recent Developments/Updates
3 Competitive Environment: Factor IX Complex Drug by Manufacturer
- 3.1 Global Factor IX Complex Drug Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Factor IX Complex Drug Revenue by Manufacturer (2021-2026)
- 3.3 Global Factor IX Complex Drug Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Factor IX Complex Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Factor IX Complex Drug Manufacturer Market Share in 2025
- 3.4.3 Top 6 Factor IX Complex Drug Manufacturer Market Share in 2025
- 3.5 Factor IX Complex Drug Market: Overall Company Footprint Analysis
- 3.5.1 Factor IX Complex Drug Market: Region Footprint
- 3.5.2 Factor IX Complex Drug Market: Company Product Type Footprint
- 3.5.3 Factor IX Complex Drug Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Factor IX Complex Drug Market Size by Region
- 4.1.1 Global Factor IX Complex Drug Sales Quantity by Region (2021-2032)
- 4.1.2 Global Factor IX Complex Drug Consumption Value by Region (2021-2032)
- 4.1.3 Global Factor IX Complex Drug Average Price by Region (2021-2032)
- 4.2 North America Factor IX Complex Drug Consumption Value (2021-2032)
- 4.3 Europe Factor IX Complex Drug Consumption Value (2021-2032)
- 4.4 Asia-Pacific Factor IX Complex Drug Consumption Value (2021-2032)
- 4.5 South America Factor IX Complex Drug Consumption Value (2021-2032)
- 4.6 Middle East & Africa Factor IX Complex Drug Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Factor IX Complex Drug Sales Quantity by Type (2021-2032)
- 5.2 Global Factor IX Complex Drug Consumption Value by Type (2021-2032)
- 5.3 Global Factor IX Complex Drug Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Factor IX Complex Drug Sales Quantity by Application (2021-2032)
- 6.2 Global Factor IX Complex Drug Consumption Value by Application (2021-2032)
- 6.3 Global Factor IX Complex Drug Average Price by Application (2021-2032)
7 North America
- 7.1 North America Factor IX Complex Drug Sales Quantity by Type (2021-2032)
- 7.2 North America Factor IX Complex Drug Sales Quantity by Application (2021-2032)
- 7.3 North America Factor IX Complex Drug Market Size by Country
- 7.3.1 North America Factor IX Complex Drug Sales Quantity by Country (2021-2032)
- 7.3.2 North America Factor IX Complex Drug Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Factor IX Complex Drug Sales Quantity by Type (2021-2032)
- 8.2 Europe Factor IX Complex Drug Sales Quantity by Application (2021-2032)
- 8.3 Europe Factor IX Complex Drug Market Size by Country
- 8.3.1 Europe Factor IX Complex Drug Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Factor IX Complex Drug Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Factor IX Complex Drug Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Factor IX Complex Drug Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Factor IX Complex Drug Market Size by Region
- 9.3.1 Asia-Pacific Factor IX Complex Drug Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Factor IX Complex Drug Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Factor IX Complex Drug Sales Quantity by Type (2021-2032)
- 10.2 South America Factor IX Complex Drug Sales Quantity by Application (2021-2032)
- 10.3 South America Factor IX Complex Drug Market Size by Country
- 10.3.1 South America Factor IX Complex Drug Sales Quantity by Country (2021-2032)
- 10.3.2 South America Factor IX Complex Drug Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Factor IX Complex Drug Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Factor IX Complex Drug Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Factor IX Complex Drug Market Size by Country
- 11.3.1 Middle East & Africa Factor IX Complex Drug Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Factor IX Complex Drug Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Factor IX Complex Drug Market Drivers
- 12.2 Factor IX Complex Drug Market Restraints
- 12.3 Factor IX Complex Drug Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Factor IX Complex Drug and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Factor IX Complex Drug
- 13.3 Factor IX Complex Drug Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Factor IX Complex Drug Typical Distributors
- 14.3 Factor IX Complex Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Factor IX Complex Drug. Industry analysis & Market Report on Factor IX Complex Drug is a syndicated market report, published as Global Factor IX Complex Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Factor IX Complex Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
